Medigus raises $5.6M, touts clinical results for acid reflux device
Israel-based Medigus secures $5.6 million in funding and reveals positive clinical outcomes from a multi-center study of its MUSE surgical endostapling device.
Medical device maker Medigus (TLV:MDGS) has some new cash and the backing of a major medical journal in hand.
Medigus Ltd.News Well, Funding Roundup, Gastrointestinalread more
Source: Mass Device - Category: Medical Equipment Authors: Arezu Sarvestani Source Type: news
More News: Acid Reflux | Funding | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Medical Devices | Middle East Health | Study